Model
Edge
Halozyme Therapeutics, Inc.
0001543792
Filing Type
4
Filing Date
8/13/2024
Updated
8/14/24, 2:57 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership